The bank upgraded the eye care stock to overweight from neutral on Thursday.
JPMorgan's call comes after Alcon — which makes Opti-Free contact lens solution — reported better-than-expected second-quarter results on Wednesday.
The company also raised its full-year earnings guidance.
However, the stock only rose marginally on the back of that report.
Alcon stock has added more than 17% in 2023.
Persons:
Alcon, David Adlington, Adlington, — CNBC's Michael Bloom
Organizations:
JPMorgan, ALC
Locations:
Alcon